$LAUR

Laureate Education, Inc. Stock 12‑Month Price Target Raised to $41.58, Implies 8% Upside

Analyst estimates compiled by FactSet show Laureate Education, Inc. average 12-month price target increased to $41.58 from $41.21. The range is $34.50 to $45. Based on the Aug. 7 close, the target implies about 8% upside. Consensus remains “Buy” with 5 Buys, 1 Hold, and 1 Sell.

Original reporting
Published Aug 8, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 3:11 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Laureate Education, Inc. Stock 12‑Month Price Target Raised to $41.58, Implies 8% Upside — source image
Decision brief

The 30-second read

$LAURBullishLow
01

Why it matters

It provides a modest sentiment tailwind via a higher average target, but lacks any new operational or financial disclosure from the company.

02

Market read

Useful for tracking Street sentiment, but not sufficient for a high-conviction trading decision without accompanying company-specific catalysts.

03

What to watch

The article does not state the rationale for the target increase, so traders cannot assess whether revisions reflect durable improvements or model tweaks.

Relevance 4/10Novelty 4/10Timing: after-hours/overnight, based on Aug. 7 close and updated analyst targets

Background

The piece summarizes FactSet-derived analyst estimates and consensus rating for Laureate Education.

Company-level read

Ticker impact

$LAURBullishMedium confidence
Context

Laureate Education’s average analyst price target rose from $41.21 to $41.58, with consensus still rated “Buy.”

Expected impact

Likely limited near-term impact unless additional upgrades or earnings catalysts follow.

Evidence & confidence

A price-target lift (implied 8% upside vs the Aug. 7 close) can support sentiment, but the text provides no new guidance, results, or operational change.

Market effects

Minimal, since this is a single-name analyst target update without sector-wide new data.

None indicated.

None indicated.

Counterpoint

Price-target changes can lag fundamentals and may not translate into realized upside if earnings or guidance disappoint.

Key entities

  • Laureate Education, Inc.

    Subject of the article, with updated average analyst price target and unchanged “Buy” consensus.

Related articles

$LAURHighAI 9/10

Laureate Education (LAUR) Q2 2026 Earnings Call Transcript

Laureate Education (NASDAQ:LAUR) reported Q2 2026 revenue of $616 million, up 8% on constant currency, and adjusted EBITDA of $251 million, up 8% on constant currency. Adjusted EPS was $1.00. Full-year 2026 guidance was raised: revenue to $1.92–$1.93 billion and adjusted EBITDA to $593–$599 million. The company repurchased $181 million of shares in H1 2026.

$LAURMedAI 8/10

Laureate Education (LAUR) Q2 2026 Earnings Call Transcript

Laureate Education (LAUR) reported Q2 2026 results and raised its full-year 2026 outlook. Through June, new and total enrollments rose 10% and 6% year over year, supporting revenue growth of 7% on a timing-adjusted constant-currency basis. Q2 revenue was $616M and adjusted EBITDA $251M. The company increased guidance midpoint by $28M revenue, $8M adjusted EBITDA, and $0.03 EPS, and announced an additional $150M share repurchase.

$LAURMed

Why Laureate Education (LAUR) Shares Are Sliding Today

Laureate Education (LAUR) shares fell about 3.6% after JPMorgan downgraded the stock to Neutral from Overweight, citing valuation concerns. Analyst Marcelo Santos set a $41 price target, noting the shares rose about 70% over the past year and now price in growth and cash generation. The stock later traded around $37.10.

$LAURMedAI 8/10

Laureate Education, Inc. Q2 2026 Earnings Call Summary

Laureate Education reported Q2 2026 momentum driven by Mexico and Peru. New enrollments rose 10% YTD, supporting 7% timing-adjusted revenue growth. Full-year 2026 guidance midpoint was raised by $28 million revenue and $8 million adjusted EBITDA, with ~50 bps margin expansion. The board authorized an additional $150 million buyback.